Found: 35
Select item for more details and to access through your institution.
Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter†.
- Published in:
- EP: Europace, 2011, v. 13, n. 8, p. 1063, doi. 10.1093/europace/eur181
- By:
- Publication type:
- Article
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Healthcare Professionals' Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications. A Survey Conducted in the Netherlands.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1061, doi. 10.2165/11635750-000000000-00000
- By:
- Publication type:
- Article
Impact of safety-related regulatory action on clinical practice: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.
- Published in:
- Kidney International, 2012, v. 82, n. 3, p. 330, doi. 10.1038/ki.2012.74
- By:
- Publication type:
- Article
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.
- Published in:
- Kidney International, 2011, v. 80, n. 3, p. 282, doi. 10.1038/ki.2011.79
- By:
- Publication type:
- Article
Connecting pre-marketing clinical research and medical practice: opinion-based study of core issues and possible changes in drug regulation.
- Published in:
- 2003
- By:
- Publication type:
- journal article
CONNECTING PRE-MARKETING CLINICAL RESEARCH AND MEDICAL PRACTICE <sbt>Opinion-based Study of Core Issues and Possible Changes in Drug Regulation</sbt>.
- Published in:
- International Journal of Technology Assessment in Health Care, 2003, v. 19, n. 1, p. 202, doi. 10.1017/S0266462303000199
- By:
- Publication type:
- Article
ASSESSMENT OF NEW CARDIOVASCULAR DRUGS Relationships Between Considerations, Professional Characteristics, and Prescribing.
- Published in:
- International Journal of Technology Assessment in Health Care, 2001, v. 17, n. 4, p. 559, doi. 10.1017/s0266462301107105
- By:
- Publication type:
- Article
The European Medicines Agency's approval of new medicines for type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2059, doi. 10.1111/dom.13349
- By:
- Publication type:
- Article
The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors.
- Published in:
- European Heart Journal, 2021, v. 42, n. 18, p. e2, doi. 10.1093/eurheartj/ehv673
- By:
- Publication type:
- Article
Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?
- Published in:
- BMC Family Practice, 2005, v. 6, p. 1, doi. 10.1186/1471-2296-6-19
- By:
- Publication type:
- Article
Understanding drug preferences, different perspectives.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 6, p. 978, doi. 10.1111/bcp.12566
- By:
- Publication type:
- Article
Additional safety risk to exceptionally approved drugs in Europe?
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 3, p. 490, doi. 10.1111/j.1365-2125.2011.03995.x
- By:
- Publication type:
- Article
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials.
- Published in:
- European Heart Journal, 2011, v. 32, n. 12, p. 1493, doi. 10.1093/eurheartj/ehr017
- By:
- Publication type:
- Article
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.
- Published in:
- European Heart Journal, 2005, v. 26, n. 19, p. 2007, doi. 10.1093/eurheartj/ehi312
- By:
- Publication type:
- Article
Risk Perception of Prescription Drugs: Results of a Survey Among Experts in the European Regulatory Network.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 145, doi. 10.1007/s00228-005-0897-6
- By:
- Publication type:
- Article
New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Late Potentials in a Porcine Model of Anterior Wall Myocardial Infarction and Their Relation to Inducible Ventricular Tachycardia.
- Published in:
- Pacing & Clinical Electrophysiology, 1992, v. 15, n. 11, p. 1760, doi. 10.1111/j.1540-8159.1992.tb02964.x
- By:
- Publication type:
- Article
Co-morbidity of 'Clinical Trial' versus 'Real-World' patients using cardiovascular drugs.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2000, v. 9, n. 7, p. 569, doi. 10.1002/pds.541
- By:
- Publication type:
- Article
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 631, doi. 10.1634/theoncologist.2017-0301
- By:
- Publication type:
- Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 102, doi. 10.1634/theoncologist.2015-0276
- By:
- Publication type:
- Article
An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice.
- Published in:
- Journal of Evaluation in Clinical Practice, 2006, v. 12, n. 6, p. 613, doi. 10.1111/j.1365-2753.2005.00625.x
- By:
- Publication type:
- Article
Patient beliefs about medicines and quality of life after a clinical medication review and follow-up by a pharmaceutical care plan: a study in elderly polypharmacy patients with a cardiovascular disorder.
- Published in:
- Journal of Pharmaceutical Health Services Research, 2015, v. 6, n. 4, p. 171, doi. 10.1111/jphs.12104
- By:
- Publication type:
- Article
The European Medicines Agency’s approval of proprotein convertase subtilisin/kexin type 9 inhibitors.
- Published in:
- European Heart Journal, 2016, v. 37, n. 6, p. 502, doi. 10.1093/eurheartj/ehv685
- By:
- Publication type:
- Article
Inclusion of patients with comorbidity and comedication in premarketing trials of cardiovascular drugs.
- Published in:
- Drug Development Research, 2000, v. 51, n. 3, p. 159, doi. 10.1002/1098-2299(200011)51:3<159::AID-DDR4>3.0.CO;2-C
- By:
- Publication type:
- Article
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 4, p. 449, doi. 10.1002/ejhf.761
- By:
- Publication type:
- Article
Post-Approval Safety Issues with Innovative Drugs: A European Cohort Study.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1105, doi. 10.1007/s40264-013-0094-y
- By:
- Publication type:
- Article
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.
- Published in:
- 2013
- By:
- Publication type:
- journal article